| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.75B | 75.66B | 73.75B | 71.40B | 55.98B | 56.07B |
| Gross Profit | 10.24B | 10.03B | 10.35B | 9.93B | 7.91B | 8.12B |
| EBITDA | 1.52B | 1.39B | 1.63B | 1.50B | 734.00M | 819.00M |
| Net Income | 650.00M | 517.00M | 718.00M | 600.00M | 227.00M | 323.00M |
Balance Sheet | ||||||
| Total Assets | 35.67B | 38.48B | 38.80B | 39.14B | 36.97B | 30.89B |
| Cash, Cash Equivalents and Short-Term Investments | 5.36B | 6.25B | 4.59B | 4.69B | 4.52B | 3.83B |
| Total Debt | 3.38B | 3.59B | 4.47B | 4.92B | 5.75B | 2.09B |
| Total Liabilities | 24.37B | 26.84B | 27.40B | 28.28B | 26.61B | 20.55B |
| Stockholders Equity | 11.29B | 11.64B | 11.40B | 10.86B | 10.36B | 10.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.80B | 504.00M | 1.24B | -264.00M | 917.00M |
| Operating Cash Flow | 0.00 | 2.91B | 633.00M | 1.41B | 223.00M | 1.18B |
| Investing Cash Flow | 0.00 | -94.00M | -80.00M | -22.00M | -2.63B | -221.00M |
| Financing Cash Flow | 0.00 | -1.15B | -659.00M | -1.16B | 3.04B | -14.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥9.16B | 10.09 | ― | 2.34% | 2.11% | 9.56% | |
76 Outperform | ¥149.32B | 11.95 | ― | 2.77% | 1.43% | 91.97% | |
69 Neutral | ¥12.07B | 18.59 | ― | 1.24% | -2.82% | -44.93% | |
64 Neutral | ¥4.68B | 56.66 | ― | 2.05% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥4.98B | 4.71 | ― | 4.23% | -5.79% | -81.85% | |
49 Neutral | ¥18.18B | 743.26 | ― | 3.24% | -3.73% | -143.19% |